1. Triple Negative Breast Cancer: Molecular Classification, Prognostic Markers and Targeted Therapies
   Narges Jafarzadeh et al, 2015, Razavi Int J Med CrossRef
2. Triple Negative Breast Cancer: Molecular Classification, Prognostic Markers and Targeted Therapies
   Narges Jafarzadeh et al, 2015, Razavi Int J Med CrossRef
3. Role of Natural Stilbenes in the Prevention of Cancer
   J. Antoni Sirerol et al, 2016, Oxidative Medicine and Cellular Longevity CrossRef
4. Association between shortage of energy supply and nuclear gene mutations leading to carcinomatous transformation
   JIANPING DU, 2016 CrossRef
5. EP4 as a Therapeutic Target for Aggressive Human Breast Cancer
   Mousumi Majumder et al, 2018, IJMS CrossRef
6. Human cytomegalovirus infection is correlated with enhanced cyclooxygenase-2 and 5-lipoxygenase protein expression in breast cancer
   Helena Costa et al, 2019, J Cancer Res Clin Oncol CrossRef
7. Androgen Receptor Actions Modify Skin Structure and Chemical Carcinogen-induced Skin Cancer Susceptibility in Mice
   Ulla Simanainen et al, 2015, HORM CANC CrossRef
8. New Insights on COX-2 in Chronic Inflammation Driving Breast Cancer Growth and Metastasis.
   Honor J Hugo et al, 2015, J Mammary Gland Biol Neoplasia CrossRef
9. Recent Progress in Triple Negative Breast Cancer Research
   Fatima Zahra Mouh et al, 2016, Asian Pacific Journal of Cancer Prevention CrossRef
10. Regular and low-dose aspirin, other non-steroidal anti-inflammatory medications and prospective risk of HER2-defined breast cancer: the California Teachers Study
    Christina A. Clarke et al, 2017, Breast Cancer Res CrossRef
11. Breast cancer cell cyclooxygenase-2 expression alters extracellular matrix structure and function and numbers of cancer associated fibroblasts
    Balaji Krishnamachary et al, 2017, Oncotarget CrossRef
12. Do Olive and Fish Oils of the Mediterranean Diet Have a Role in Triple Negative Breast Cancer Prevention and Therapy? An Exploration of Evidence in Cells and Animal Models
    Micah G. Donovan et al, 2020, Front. Nutr. CrossRef
13. Prostaglandin E2 Receptor 4 (EP4) as a Therapeutic Target to Impede Breast Cancer-Associated Angiogenesis and Lymphangiogenesis
    Guillermo Antonio De Paz Linares et al, 2021, Cancers CrossRef
14. Combination of Fish Oil and Selenium Enhances Anticancer Efficacy and Targets Multiple Signaling Pathways in Anti-VEGF Agent Treated-TNBC Tumor-Bearing Mice
    Chih-Hung Guo et al, 2021, Marine Drugs CrossRef
15. Multi-Gene Testing Overview with a Clinical Perspective in Metastatic Triple-Negative Breast Cancer.
    Martina Dameri et al, 2021, Int J Mol Sci CrossRef
16. Curcumin and its nano-formulations: Defining triple-negative breast cancer targets through network pharmacology, molecular docking, and experimental verification
    Zhicheng Deng et al, 2022, Front. Pharmacol. CrossRef
17. Enhanced characterization of breast cancer phenotypes using Raman micro-spectroscopy on stainless steel substrate
    Giju Thomas et al, 2023, Anal. Methods CrossRef
18. Narirutin downregulates lipoxygenase-5 expression and induces G0/G1 arrest in triple-negative breast carcinoma cells
    Shilpi Singh et al, 2023, Biochimica et Biophysica Acta (BBA) - General Subjects CrossRef
19. Overcoming the Challenges of Phytochemicals in Triple Negative Breast Cancer Therapy: The Path Forward
    Mohammed Alaouna et al, 2023, Plants CrossRef
20. In silico screening, synthesis, characterization and biological evaluation of novel anticancer agents as potential COX-2 inhibitors
    Ankita Sahu et al, 2023, DARU J Pharm Sci CrossRef
21. Association of cyclooxygenase-2 expression with endoplasmic reticulum stress and autophagy in triple-negative breast cancer
    Haechan Lee et al, 2023, PLoS ONE CrossRef
22. Harnessing the synergistic potential of NK1R antagonists and selective COX-2 inhibitors for simultaneous targeting of TNBC cells and cancer stem cells
    Madhu Tanya Singh et al, 2024, Journal of Drug Targeting CrossRef